N/A
N=30
Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury
Acute Kidney Injury
Bottom Line
View on ClinicalTrials.gov: NCT02165072 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Jun 2016
Primary outcome: Primary: Maximum and Minimum Diameters of the Inferior Vena Cava in Patients With Acute Kidney Injury — 1.8; 1.2 cm
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Texas Tech University Health Sciences Center
- Primary completion
- Oct 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Maximum and Minimum Diameters of the Inferior Vena Cava in Patients With Acute Kidney Injury |
1.8; 1.2 | — |
| PRIMARY Percent Collapse of the Inferior Vena Cava in Patients With Acute Kidney Injury |
32 | — |
Summary
This is an observational study that will examine the possibility of determining the type of Acute Kidney Injury (AKI) using bedside ultrasound machines.
Eligibility Criteria
Inclusion Criteria
- Creatinine of 1.7 mg/100ml or higher for less than 24 hours from baseline creatinine ≤1.2 or with unknown baseline creatinine
- Age range: 18-89 years
- Age range ≥ 18
Exclusion Criteria
- Only chronic renal disease will exclude a patient from our study regardless of past medical history and medications they are taking. (For the purposes of this study, any patient with creatinine higher than 1.2 mg /100ml for more than 24 hours will be identified as having chronic renal disease.)
Data sourced from ClinicalTrials.gov (NCT02165072). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.